Dotmatics

ABC News: How AI is Transforming Drug Discovery

ABC News features an interview with Christian Olsen, VP of Biologics at Dotmatics, highlighting how AI is revolutionizing drug discovery by drastically reducing development time and costs through accelerated target identification, high-throughput screening, and data-driven insights, enabling faster breakthroughs in diseases like cancer, diabetes, cardiovascular conditions, and neurology.

ABC News: How AI is Transforming Drug Discovery

Latest Blogs

Case Studies

White Papers

Upcoming Events

News

Search

WSET 1-24-25 - ABC News - Christian Olsen - AI Drugs

Press O for more options

Video Thumbnail

Click for sound

5:40

Artificial intelligence is revolutionizing drug discovery, potentially slashing the decade-long timeline and billion-dollar costs associated with bringing new medicines to market. In this interview, Christian Olsen, VP of Biologics at Dotmatics, discusses how AI is reshaping pharmaceutical R&D by accelerating drug target identification and high-throughput screening. By leveraging vast datasets and automation, AI enables scientists to uncover new treatment strategies and revisit overlooked therapeutic opportunities.

Discover how AI is driving breakthroughs in cancer, diabetes, cardiovascular disease, and neurology, and how Dotmatics is empowering pharma and biotech companies to develop life-saving treatments faster than ever.

Learn More About Dotmatics

Schedule a meeting with our product experts today for a personalized demo of Luma's AI capabilities.